TABLE 1

Clinical Characteristics

CharacteristicCRD patientsDisease control subjects
n4233
Sex (M/F)35/724/9
Age (y)68.1 ± 7.765.1 ± 11.1
Height (cm)161 ± 8159 ± 7
Weight (kg)53.9 ± 10.360.5 ± 9.4*
Origin of lung disease (%)
 COPD19 (45.2)
 Tuberculosis sequela14 (33.3)
 IIP2 (5.0)
 Other7 (17.5)
Risk factor (%)
 Hypertension23 (54.8)19 (57.6)
 Hyperlipidemia9 (22.5)11 (33.3)
 Diabetes mellitus7 (16.7)11 (33.3)
 Smoking32 (76.2)16 (48.5)*
Pulmonary function testNot done
 VC (L)2.33 ± 0.89
 FEV1 (L)1.33 ± 0.57
 Dlco (%)67.4 ± 32.7
CPET by treadmillNot done
 Vo2 (mL/kg/min)17.5 ± 4.9
 Pao2 (mm Hg)61.6 ± 13.5
 HR/THR (%)86.6 ± 14.4
 Double product25,566 ± 6,281
Myocardial perfusion imaging by upright ergometer
 HR/THR85.8 ± 13.898.3 ± 22.5*
 Double product24,828 ± 6,33130,384 ± 7,255*
  • * P < 0.05.

  • Origins of lung disease in patients designated as Other were post lung cancer surgery (2 patients), pneumoconiosis (2 patients), bronchiectasis (1 patient), pyothorax (1 patient), and giant bulla (1 patient).

  • At peak exercise.

  • IIP = idiopathic interstitial pneumonia; VC = vital capacity; FEV1 = forced expiratory volume in 1 s; Dlco = diffusing capacity of lung for carbon monoxide; Vo2 = volume of oxygen; Pao2 = partial pressure of oxygen, arterial; HR/THR = heart rate/target heart rate.

  • Data are presented as mean ± SD or % of patients.